Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Constantinescu

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|October 16, 2023
Leukemic conversion involving <i>RAS</i> mutations of type 1 <i>CALR</i>-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case reportPetruta Gurban, Cristina Mambet, Anca Botezatu, et al.
Angewandte Chemie (International Ed. in English)|February 28, 2025
LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding ModeDarius Mazhari Dorooee, Séverine Ravez, Didier Vertommen, et al.
Blood|March 24, 2019
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutantsChristian Pecquet, Ilyas Chachoua, Anita Roy, et al.
Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
Hemasphere|February 24, 2021
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open QuestionsPeter Valent, Alberto Orfao, Stefan Kubicek, et al.
Cancer Discovery|September 27, 2015
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited SusceptibilityAlberto Martín-Lorenzo, Julia Hauer, Carolina Vicente-Dueñas, et al.
The Journal of Experimental Medicine|March 26, 2008
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemiaElisabetta Flex, Valentina Petrangeli, Lorenzo Stella, et al.
Leukemia|April 26, 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in miceChristophe Willekens, Lucie Laplane, Tracy Dagher, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|October 16, 2023
Leukemic conversion involving <i>RAS</i> mutations of type 1 <i>CALR</i>-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case reportPetruta Gurban, Cristina Mambet, Anca Botezatu, et al.
Angewandte Chemie (International Ed. in English)|February 28, 2025
LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding ModeDarius Mazhari Dorooee, Séverine Ravez, Didier Vertommen, et al.
Blood|March 24, 2019
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutantsChristian Pecquet, Ilyas Chachoua, Anita Roy, et al.
Blood|October 10, 2015
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patientsXénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood|November 8, 2019
JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia veraAmi B Patel, Anca Franzini, Emilie Leroy, et al.
Oncogene|June 24, 2020
Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasmsMira El-Khoury, Xénia Cabagnols, Matthieu Mosca, et al.
Hemasphere|February 24, 2021
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open QuestionsPeter Valent, Alberto Orfao, Stefan Kubicek, et al.
Cancer Discovery|September 27, 2015
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited SusceptibilityAlberto Martín-Lorenzo, Julia Hauer, Carolina Vicente-Dueñas, et al.
The Journal of Experimental Medicine|March 26, 2008
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemiaElisabetta Flex, Valentina Petrangeli, Lorenzo Stella, et al.
Leukemia|April 26, 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in miceChristophe Willekens, Lucie Laplane, Tracy Dagher, et al.
Pageof 18